1. Home
  2. CVM vs VRAR Comparison

CVM vs VRAR Comparison

Compare CVM & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • VRAR
  • Stock Information
  • Founded
  • CVM 1983
  • VRAR 2016
  • Country
  • CVM United States
  • VRAR United States
  • Employees
  • CVM N/A
  • VRAR N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • VRAR Retail: Computer Software & Peripheral Equipment
  • Sector
  • CVM Health Care
  • VRAR Technology
  • Exchange
  • CVM Nasdaq
  • VRAR Nasdaq
  • Market Cap
  • CVM 40.1M
  • VRAR 42.4M
  • IPO Year
  • CVM 1987
  • VRAR 2021
  • Fundamental
  • Price
  • CVM $0.40
  • VRAR $1.55
  • Analyst Decision
  • CVM
  • VRAR Strong Buy
  • Analyst Count
  • CVM 0
  • VRAR 1
  • Target Price
  • CVM N/A
  • VRAR $4.67
  • AVG Volume (30 Days)
  • CVM 1.2M
  • VRAR 309.0K
  • Earning Date
  • CVM 02-14-2025
  • VRAR 02-13-2025
  • Dividend Yield
  • CVM N/A
  • VRAR N/A
  • EPS Growth
  • CVM N/A
  • VRAR N/A
  • EPS
  • CVM N/A
  • VRAR N/A
  • Revenue
  • CVM N/A
  • VRAR $9,230,197.00
  • Revenue This Year
  • CVM N/A
  • VRAR $39.02
  • Revenue Next Year
  • CVM N/A
  • VRAR N/A
  • P/E Ratio
  • CVM N/A
  • VRAR N/A
  • Revenue Growth
  • CVM N/A
  • VRAR N/A
  • 52 Week Low
  • CVM $0.33
  • VRAR $0.50
  • 52 Week High
  • CVM $2.50
  • VRAR $7.00
  • Technical
  • Relative Strength Index (RSI)
  • CVM 45.54
  • VRAR 39.84
  • Support Level
  • CVM $0.39
  • VRAR $1.55
  • Resistance Level
  • CVM $0.68
  • VRAR $1.73
  • Average True Range (ATR)
  • CVM 0.06
  • VRAR 0.18
  • MACD
  • CVM 0.01
  • VRAR -0.01
  • Stochastic Oscillator
  • CVM 18.86
  • VRAR 10.58

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.

Share on Social Networks: